Your institution may have access to this item. Find your institution then sign in to continue.
Title
AstraZeneca adopts CRISPR across drug discovery.
Abstract
The article reports on the announcement of AstraZeneca PLC regarding research collaborations with four leading players in the new space of clustered, regularly interspaced, short palindromic repeats (CRISPR) engineering.